4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Clinical Cytology - Oral Presentations<br />
TREATMENT OUTCOMES OF HEPATOCELLULAR CARCINOMA PROVEN BY FINE<br />
NEEDLE ASPIRATION CYTOLOGY: A SINGLE CENTRE EXPERIENCE<br />
Mrzljak A, Čolić Cvrlje V, Kardum-Skelin I, Škegro D, Filipec-Kanižaj T, Šušterčić D<br />
Department of Medicine, University Hospital Merkur, Zagreb, Croatia<br />
Hepatocellular carcinoma (HCC) mostly occurs in chronic liver disease and cirrhosis.<br />
Surgical resection and liver transplantation (LT) represent potentially curative treatments<br />
of choice and if not feasible, palliative strategies such as percutaneous interventional<br />
techniques (PITs) and systemic therapy (ST) are considered. Elevated alfafetoprotein,<br />
typical imaging pattern, needle core biopsy (NCB) and fine needle aspiration<br />
cytology (FNAC) complement diagnostic assessment of HCC.<br />
We have retrospectively analyzed HCC diagnosed by FNAC at our institution from 2004-<br />
2009 regarding treatment options. Ultrasound guided FNAC was performed in cases of<br />
contraindications for NCB. No complications were documented, except for mild transitory<br />
discomfort at the site of puncture. The diagnosis was verified by May-Grunwald-<br />
Giemsa (MGG) staining and immunohistochemistry. In overall of 62 patients, HCC developed<br />
in 61% and 39% in cirrhotic and non-cirrhotic liver, respectively. Underlying cause<br />
of liver disease was alcohol abuse in 32% and viral diseases in 13% of cases. In the setting<br />
of cirrhosis 16% of patients underwent PITs, 18% liver transplantation, 26% ST and<br />
40% symptomatic therapy. In non-cirrhotic patients resection, ST, symptomatic therapy<br />
and PIT were applied in 46%, 25%, 25% and 4%, respectively. Pathohistology of resected<br />
and explanted livers (18 cases) confirmed the initial diagnosis.<br />
Our observations demonstrate that screening of high-risk groups and early identification<br />
of HCC should be addressed more intensely, since only early stage of HCC offers potentially<br />
curative treatment options. FNAC offers minimally invasive, rapid and uncomplicated<br />
diagnostic approach in the setting of abnormal coagulation and ascites commonly<br />
seen in advanced liver disease, providing therefore simple and effective diagnostic tool.<br />
anna.mrzljak@gmail.com<br />
97<br />
4 th <strong>Croatian</strong> <strong>Congress</strong> of Clinical Cytology / 1 st <strong>Croatian</strong> Symposium of Analytical Cytology / 2 nd <strong>Croatian</strong> Symposium of Cytotechnology